SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266 | -6.3% | 9,648 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $284 | -11.8% | 9,451 | +6.2% | 0.00% | 0.0% |
| Q1 2023 | $322 | +3.9% | 8,901 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $310 | -99.9% | 8,701 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $345,000 | +12.7% | 10,219 | -3.6% | 0.00% | 0.0% |
| Q2 2022 | $306,000 | -8.9% | 10,604 | +1.7% | 0.00% | 0.0% |
| Q1 2022 | $336,000 | +7.7% | 10,423 | -2.7% | 0.00% | 0.0% |
| Q4 2021 | $312,000 | +3.0% | 10,709 | -5.9% | 0.00% | 0.0% |
| Q3 2021 | $303,000 | -1.0% | 11,380 | +14.5% | 0.00% | 0.0% |
| Q2 2021 | $306,000 | +22.4% | 9,940 | +3.8% | 0.00% | 0.0% |
| Q1 2021 | $250,000 | +4.2% | 9,578 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $240,000 | – | 9,578 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |